On Invalid Date, Protara Therapeutics (NASDAQ: TARA) reported Q4 2023 earnings per share (EPS) of -$0.90, up 73.99% year over year. Total Protara Therapeutics earnings for the quarter were -$10.22 million. In the same quarter last year, Protara Therapeutics's earnings per share (EPS) was -$3.46.
As of Q2 2024, Protara Therapeutics's earnings has grown year over year. Protara Therapeutics's earnings in the past year totalled -$40.42 million.
What is TARA's earnings date?
Protara Therapeutics's earnings date is Invalid Date. Add TARA to your watchlist to be reminded of TARA's next earnings announcement.
What was TARA's revenue last quarter?
On Invalid Date, Protara Therapeutics (NASDAQ: TARA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Protara Therapeutics's revenue was $0.00.
What was TARA's revenue growth in the past year?
As of Q2 2024, Protara Therapeutics's revenue has grown null year over year. Protara Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.